288 related articles for article (PubMed ID: 26578231)
1. Impact of Genetic Counseling and Testing on Altruistic Motivations to Test for BRCA1/2: a Longitudinal Study.
Garg R; Vogelgesang J; Kelly K
J Genet Couns; 2016 Jun; 25(3):572-82. PubMed ID: 26578231
[TBL] [Abstract][Full Text] [Related]
2. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
Geller G; Doksum T; Bernhardt BA; Metz SA
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
[TBL] [Abstract][Full Text] [Related]
3. Cancer Risk Information Sharing: The Experience of Individuals Receiving Genetic Counseling for BRCA1/2 Mutations.
Chopra I; Kelly KM
J Health Commun; 2017 Feb; 22(2):143-152. PubMed ID: 28112991
[TBL] [Abstract][Full Text] [Related]
4. "I Don't Want to Be an Ostrich": Managing Mothers' Uncertainty during BRCA1/2 Genetic Counseling.
Fisher CL; Roccotagliata T; Rising CJ; Kissane DW; Glogowski EA; Bylund CL
J Genet Couns; 2017 Jun; 26(3):455-468. PubMed ID: 27473644
[TBL] [Abstract][Full Text] [Related]
5. Cancer genetics knowledge and beliefs and receipt of results in Ashkenazi Jewish individuals receiving counseling for BRCA1/2 mutations.
Kelly K; Leventhal H; Marvin M; Toppmeyer D; Baran J; Schwalb M
Cancer Control; 2004; 11(4):236-44. PubMed ID: 15284715
[TBL] [Abstract][Full Text] [Related]
6. Effect on perceived control and psychological distress of genetic knowledge in women with breast cancer receiving a BRCA1/2 test result.
Brédart A; Kop JL; De Pauw A; Caron O; Fajac A; Noguès C; Stoppa-Lyonnet D; Dolbeault S
Breast; 2017 Feb; 31():121-127. PubMed ID: 27837705
[TBL] [Abstract][Full Text] [Related]
7. Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1/2 mutations.
Kelly KM; Senter L; Leventhal H; Ozakinci G; Porter K
Patient Educ Couns; 2008 Jan; 70(1):135-42. PubMed ID: 17988821
[TBL] [Abstract][Full Text] [Related]
8. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
[TBL] [Abstract][Full Text] [Related]
9. Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.
Kinney AY; Butler KM; Schwartz MD; Mandelblatt JS; Boucher KM; Pappas LM; Gammon A; Kohlmann W; Edwards SL; Stroup AM; Buys SS; Flores KG; Campo RA
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25376862
[TBL] [Abstract][Full Text] [Related]
10. "For all my family's sake, I should go and find out": an Australian report on genetic counseling and testing uptake in individuals at high risk of breast and/or ovarian cancer.
Wakefield CE; Ratnayake P; Meiser B; Suthers G; Price MA; Duffy J; Tucker K;
Genet Test Mol Biomarkers; 2011 Jun; 15(6):379-85. PubMed ID: 21254855
[TBL] [Abstract][Full Text] [Related]
11. The decision to test in women receiving genetic counseling for BRCA1 and BRCA2 mutations.
Kelly K; Leventhal H; Andrykowski M; Toppmeyer D; Much J; Dermody J; Marvin M; Baran J; Schwalb M
J Genet Couns; 2004 Jun; 13(3):237-57. PubMed ID: 15604634
[TBL] [Abstract][Full Text] [Related]
12. Subjective and objective risk of breast cancer in Ashkenazi Jewish individuals at risk for BRCA1/2 mutations.
Kelly K; Leventhal H; Marvin M; Toppmeyer D; Much J; Dermody J; Baran J; Schwalb M
Genet Test; 2004; 8(2):139-47. PubMed ID: 15345111
[TBL] [Abstract][Full Text] [Related]
13. Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing.
Schwartz MD; Kaufman E; Peshkin BN; Isaacs C; Hughes C; DeMarco T; Finch C; Lerman C
J Clin Oncol; 2003 Nov; 21(21):4034-41. PubMed ID: 14581427
[TBL] [Abstract][Full Text] [Related]
14. Genetic counseling for BRCA1/BRCA2 testing.
Schneider KA
Genet Test; 1997; 1(2):91-8. PubMed ID: 10464632
[TBL] [Abstract][Full Text] [Related]
15. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
[TBL] [Abstract][Full Text] [Related]
16. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
17. BRCA1/2 genetic testing in the community setting.
Chen WY; Garber JE; Higham S; Schneider KA; Davis KB; Deffenbaugh AM; Frank TS; Gelman RS; Li FP
J Clin Oncol; 2002 Nov; 20(22):4485-92. PubMed ID: 12431973
[TBL] [Abstract][Full Text] [Related]
18. Issues of concern in risk assessment, genetic counseling, and genetic testing of younger breast cancer patients in Japan.
Bando H
Breast Cancer; 2014 Nov; 21(6):656-63. PubMed ID: 23754181
[TBL] [Abstract][Full Text] [Related]
19. Understanding of BRCA1/2 genetic tests results: the importance of objective and subjective numeracy.
Hanoch Y; Miron-Shatz T; Rolison JJ; Ozanne E
Psychooncology; 2014 Oct; 23(10):1142-8. PubMed ID: 24733657
[TBL] [Abstract][Full Text] [Related]
20. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.
Schwartz MD; Peshkin BN; Hughes C; Main D; Isaacs C; Lerman C
J Clin Oncol; 2002 Jan; 20(2):514-20. PubMed ID: 11786581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
